MSME (Udyam registered) Ministry of MSME
- Udyam number
- UDYAM-MH-33-0179355
SRS Formulations Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹11.78 Cr
▲ 4591% YoY
Net loss · FY 2025
₹13.47 Cr
Net margin -114.4%
EBITDA · FY 2025
-₹9.55 Cr
EBITDA margin -81.1%
Authorised capital
₹70 Cr
Registered with MCA
Paid-up capital
₹4.15 Cr
Issued & subscribed
Open charges
₹4.8 Cr
Satisfied ₹12 Cr
Company age
12 yrs
Est. 2014
Employees · EPFO
25
Provident fund records
About SRS Formulations Private Limited
Data last updated:
SRS Formulations Private Limited is a private limited company based in Mumbai, Maharashtra, India, a subsidiary of Srs Pharmaceuticals Private Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 09 July 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2014PTC255945. Its GSTIN is 27AAMCA7379R2ZI (Maharashtra). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹70 Cr and a paid-up capital of ₹4.15 Cr. It was formerly known as Adkure Pharmaceuticals Private Limited and Adkure Technologies Private Limited. It is led by directors Kishen Jee Kaul and Manoj Kumar Sharma.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹11.78 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹13.47 Cr (net margin -114.4%) and EBITDA of -₹9.55 Cr (EBITDA margin -81.1%).
The company has about 25 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹4.8 Cr and satisfied charges of ₹12 Cr on record. Court records list 4 cases involving the company, including 4 filed against it; 1 case is pending.
SRS Formulations Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-MH-33-0179355). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website adkure.com.
Company details
CIN U74999MH2014PTC255945
Registration Number 255945
Incorporation Date 09 July 2014
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Parent Company Srs Pharmaceuticals Private Limited
Compliance Status Active Compliant
MSME Classification MSME
Udyam Registration UDYAM-MH-33-0179355
Name history
SRS Formulations has undergone 2 name changes throughout its history. The company was previously known as Adkure Pharmaceuticals Private Limited, and Adkure Technologies Private Limited. The current legal name is Srs Formulations Private Limited.
| Company Name | Status |
|---|---|
| SRS Formulations Private Limited | Current |
| Adkure Pharmaceuticals Private Limited | Previous |
| Adkure Technologies Private Limited | Previous |
Recognitions & Rankings of SRS Formulations
Contact details
SRS Formulations Private Limited's registered office is in Mumbai, Maharashtra. Its website is adkure.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressU No. 504 Marathon Max, Link Road Mulund West, Mumbai, Maharashtra, India – 400080
- IndustryPharma, Drug Formulation & Development
To see the full contact details of SRS Formulations Private Limited, buy the company report.
Comprehensive company report
SRS Formulations Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of SRS Formulations is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of SRS Formulations Private Limited, buy the company report.
Financials of SRS Formulations Private Limited
FY 2025 filings availableSRS Formulations Private Limited reported revenue of ₹11.78 Cr (up 4591% YoY) for FY 2025.
Revenue · FY 2025
₹11.78 Cr ▲ 4591%
Net loss · FY 2025
₹13.47 Cr margin -114.4%
EBITDA · FY 2025
-₹9.55 Cr margin -81.1%
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹9.55 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹13.47 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -81.1% | ||||
| Net Profit Margin | -114.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of SRS Formulations Private Limited, buy the company report.
Board of directors of SRS Formulations Private Limited
SRS Formulations has 2 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kishen Jee Kaul | Director | 10 Nov 2023 | 2 Years 11 Months | Current |
| Manoj Kumar Sharma | Director | 26 Dec 2022 | 3 Years 9 Months | Current |
Auditor
SRS Formulations Private Limited is audited by M. Sheth & Co. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M. Sheth & Co. | FY 2023 | 116371W |
Shareholding
The shareholding of SRS Formulations Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of SRS Formulations Private Limited, buy the company report.
Charges & borrowings
Open charges
₹4.8 Cr
Satisfied charges
₹12 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 07 Jul 2025 | 101128823 | Hdfc Bank Limited | ₹4.8 Cr | Open | |
| 17 Feb 2017 | 100082595 | Sidbi | ₹12 Cr | Satisfied |
To see the full charge records of SRS Formulations Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
SRS Formulations Private Limited has 4 court cases on record: 4 filed against it. 1 case is pending and 3 are disposed.
Total cases
4
Filed against the company
4
Pending
1
Disposed
3
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 2 | 1 |
| High courts | 1 | 1 | 0 |
| NCLT | 1 | 1 | 0 |
Cases on record (4 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Thane, Maharashtra | Court case (Sum.Civ.Suit) | Filed against the company by M/S Drystar India Pvt Ltd Through Kiran R Marchande | Pending |
| District court, Thane, Maharashtra | Court case (Sum.Civ.Suit) | Filed against the company by Omax Elevators India Pvt. Ltd. | Disposed |
| Bombay High Court | Court case (CARBP) | Filed against the company by SRS Pharmaceuticals Pvt Ltd | Disposed |
| NCLT, Mumbai | Insolvency matter | Filed against the company by Small Industries Development Bank of India | Disposed |
To see the full case history of SRS Formulations Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
SRS Formulations Private Limited has 4 MSME Form 1 returns on record between 2018 and 2024, listing 67 overdue payments to 46 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 46)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| SRS Pharmaceuticals Private Limited | |||
| an individual supplier | |||
| Lab and Life Instruments Private Limited | |||
| an individual supplier | |||
| an individual supplier |
To see the full MSME payment records of SRS Formulations Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
GST
SRS Formulations has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAMCA7379R2ZI | Maharashtra | Active | 15 Dec 2022 |
To see the full GST registrations and return filing status of SRS Formulations Private Limited, buy the company report.
Recent activity
SRS Formulations Private Limited has 8 board changes on record since 2016: 2 appointments and 6 cessations. The latest: Kishen Jee Kaul ceased to be Additional Director on 28 Dec 2023.
AGM
Srs Formulations Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 4.80 Cr with Charge ID 101128823 was registered on 07 Jul 2025.
Filing
Srs Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Ceased
Kishen Jee Kaul ceased to be Additional Director.
Ceased
Manoj Kumar Sharma ceased to be Additional Director.
Ceased
Suchet Shyamsunder Rastogi ceased to be Director.
Appointed
Kishen Jee Kaul was appointed as Director.
Ceased
Dipti Kothari ceased to be Director.
Ceased
Kalpana Jain Bhikham Chand ceased to be Director.
Appointed
Manoj Kumar Sharma was appointed as Director.
Charges
A charge registered on 17 Feb 2017 via Charge ID 100082595 with Sidbi was fully satisfied on 23 Nov 2022.
Charges
A charge with Sidbi amounted to Rs. 12.00 Cr with Charge ID 100082595 was registered on 17 Feb 2017.
2 earlier events are in the company report.
Frequently asked questions
SRS Formulations is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 09 July 2014 (12+ years old) and is registered under CIN U74999MH2014PTC255945.
SRS Formulations has 2 current directors:
- Kishen Jee Kaul - Director
- Manoj Kumar Sharma - Director
The latest financial statements of SRS Formulations on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of SRS Formulations is 27AAMCA7379R2ZI, registered in Maharashtra. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of SRS Formulations is U74999MH2014PTC255945. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
SRS Formulations has 4 court cases on record: 4 filed against it. 1 is pending. Most are in the district courts.
SRS Formulations was incorporated on 09 July 2014, making it 12+ years old. It is registered with the Registrar of Companies, Mumbai.
Kishen Jee Kaul ceased to be Additional Director on 28 Dec 2023. Manoj Kumar Sharma ceased to be Additional Director on 28 Dec 2023. Suchet Shyamsunder Rastogi ceased to be Director on 21 Nov 2023. SRS Formulations has 8 board changes on record in total.
Yes, SRS Formulations is registered as an MSME under Udyam registration (number: UDYAM-MH-33-0179355).
SRS Formulations has 4 MSME Form 1 returns on record between 2018 and 2024, listing 67 overdue payments to 46 micro and small suppliers. The latest return was filed on 30 Apr 2024.
SRS Formulations can be reached through the website adkure.com. Its registered office is in Mumbai, Maharashtra, India.